The IANZ Good Manufacturing Practice (GMP) (Cosmetics) Compliance Monitoring Programme has been commissioned to support a New Zealand Government official assurance scheme to enable access of New Zealand manufactured cosmetics into the People’s Republic of China.
While Registration in the Programme is likely to be a necessity for manufacturers whose products are intended for export to China, the Programme is available to all New Zealand cosmetics manufacturers who wish to demonstrate their compliance with the GMP standards through an independent third-party agency, irrespective of where their products are sold.
In New Zealand, the definition of a “cosmetic” is primarily governed by the Cosmetic Products Group Standard 2020, administered by the Environmental Protection Authority (EPA). For the purpose of this IANZ programme, it also includes any product regulated in China under the CSAR (see opposite).
On application, manufacturers’ facilities and processes are inspected against the guidelines set out in the internationally recognised GMP standard for the cosmetics industry: ISO 22716 Cosmetics – Good Manufacturing Practices (GMP) – Guidelines on Good Manufacturing Practices. Once compliance has been demonstrated, Registration is granted by IANZ and the manufacturer goes on a regular monitoring programme to verify on-going compliance.
This GMP Compliance Monitoring Programme is restricted to the cosmetics industry and ISO 22716 only. IANZ does not inspect against, nor grant Registration for, other GMP codes of practice in other industry sectors.
A Fee Schedule can be found under the Forms section on this page.
Cosmetic products intended for export to China must first be registered in China by the responsible Chinese regulatory authority, the National Medical Products Administration (NMPA) under the Cosmetic Supervision and Administration Regulation (CSAR). This registration process, in accordance with the CSAR, is the responsibility of the New Zealand exporter or product owner – IANZ has no direct role in this process. However, for some cosmetic types, the requirement for safety assessment of the product through animal testing can be avoided by provision of documentation, including evidence of the GMP compliance status of the manufacturer (who may not necessarily be the exporter or product owner) of the product.
This GMP compliance documentation must be issued by the competent authority of the exporting country. The New Zealand Government official assurances are provided by the Communications, Infrastructure and Trade Branch of the Ministry of Business, Innovation and Employment (MBIE) and are based on Registration under the IANZ GMP (Cosmetics) Compliance Monitoring Programme.
Exporters, prior to applying for registration of their product(s) in China, should ensure that their chosen manufacturer is Registered under the IANZ GMP (Cosmetics) Compliance Monitoring Programme. The IANZ-issued Registration documentation can then uploaded by the exporter into the MBIE Business Connect portal. IANZ will validate the authenticity of the submitted documentation, following which MBIE will issue official assurances, to be used as part of the product registration application with the NMPA.
The MBIE official assurances are issued to individual exporters, so each exporter must seek validation of their manufacturers’ GMP compliance status, even if that manufacturer has been validated by other exporters.
It is anticipated the process will require revalidation on a periodic basis given both the IANZ Registration documentation and the MBIE official assurances carry expiry dates.
No items found in this list.
No items found in this list.
